Did you miss the presentation last week by CEO Carolina Trkulja on how Fluicell is transforming how we treat diseases with tissue-based screening technologies and regenerative medicine products?
In her talk, Carolina discussed how Fluicell’s high precision tissue engineering technologies creates a path towards a curative solution for type 1 diabetes, based on bioprinted artificial pancreatic islets.
Watch the recorded presentation below. Now available with subtitles in English.